Cited by 283Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK PathwaysProtein Tyrosine Phosphatases

Identification of an Extracellular Signal-regulated Kinase (ERK) Docking Site in Ribosomal S6 Kinase, a Sequence Critical for Activation by ERK in Vivo

Open access
Smith, Jeffrey A., Poteet-Smith, Celeste E., Malarkey, Kevin, Sturgill, Thomas W.·1999·Journal of Biological Chemistry

Abstract

Glutathione S-transferase (GST)-fusion proteins containing the carboxyl-terminal tails of three p90 ribosomal S6 kinase (RSK) isozymes (RSK1, RSK2, and RSK3) interacted with extracellular signal-regulated kinase (ERK) but not c-Jun-NH2-kinase (JNK) or p38 mitogen-activated protein kinase (MAPK). Within the carboxyl-terminal residues of the RSK isozymes is a region of high conservation corresponding to residues 722LAQRRVRKLPSTTL735 in RSK1. Truncation of the carboxyl-terminal 9 residues, 727VRKLPSTTL735, completely eliminated the interaction of the GST-RSK1 fusion protein with purified recombinant ERK2, whereas the truncation of residues 731PSTTL735 had no effect on the interaction with purified ERK2. ERK1 and ERK2 co-immunoprecipitated with hemagglutinin-tagged wild type RSK2 (HA-RSK2) in BHK cell cytosol. However, ERK did not co-immunoprecipitate with HA-RSK2((1-729)), a mutant missing the carboxyl-terminal 11 amino acids, similar to the minimal truncation that eliminated in vitro interaction of ERK with the GST-RSK1 fusion protein. Kinase activity of HA-RSK2 increased 6-fold in response to insulin. HA-RSK2((1-729)) had a similar basal kinase activity to that of HA-RSK2 but was not affected by insulin treatment. Immunoprecipitated HA-RSK2 and HA-RSK2((1-729)) could be activated to the same extent in vitro by active ERK2, demonstrating that HA-RSK2((1-729)) was properly folded. These data suggest that the conserved region of the RSK isozymes (722LAQRRVRKL730 of RSK1) provides for a specific ERK docking site approximately 150 amino acids carboxyl-terminal to the nearest identified ERK phosphorylation site (Thr573). Complex formation between RSK and ERK is essential for the activation of RSK by ERK in vivo. Comparison of the docking site of RSK with the carboxyl-terminal tails of other MAPK-activated kinases reveals putative docking sites within each of these MAPK-targeted kinases. The number and placement of lysine and arginine residues within the conserved region correlate with specificity for activation by ERK and p38 MAPKs in vivo.

Integrity signals

Registry

Crossref · 10.1074/jbc.274.5.2893

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MAPK scaffolding proteins JIP1 and PEA-15 and substrates RSK1, MK2, and MEF2a also contain a linear KIM domain that mediates MAPK binding in the cell.

    “Notably, MAPK scaffolding proteins (JNK-interacting protein, JIP1; 29 phosphoprotein enriched in astrocytes 15, PEA-15 30 ) and substrates (Ribosomal protein S6 kinase alpha-1, RSK1; 31 MAP kinase-activated protein kinase 2, MK2; 32 and myocyte enhancer factor 2A, MEF2a 33 ) also contain linear KIM domain, which mediates MAPK binding in the cell.”

    From Molecular basis of MAP kinase regulation (2013) · cites this paper as [31]

The citation lists haven’t been fetched yet

References 36 · Cited by 283

Authors
Smith, J. A., Poteet-Smith, C. E., Malarkey, K., & Sturgill, T. W.
Affiliations
Howard Hughes Medical Institute (US)
Corresponding author
Sturgill, Thomas W.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1999-01
Volume
274
Issue
5
Pages
2893-2898
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2018221682
Cited by
283
References
36
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 9 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 6
FWCI
9.13
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK41077, R01DK041077)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
RSK, ERK2, RSK1, RSK2, carboxyl-terminal tail, protein-protein interaction, MAPK signaling, insulin, kinase activation, c-Jun NH2-kinase, p38 MAPK, GST fusion protein, co-immunoprecipitation
MeSH terms
Amino Acid Sequence, Animals, Binding Sites, Cells, Cultured, Enzyme Activation, Cricetinae, Isoenzymes, Molecular Sequence Data, Structure-Activity Relationship, Sequence Alignment, Conserved Sequence, Protein Serine-Threonine Kinases, Sequence Homology, Amino Acid, Calcium-Calmodulin-Dependent Protein Kinases, COS Cells, Ribosomal Protein S6 Kinases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review